The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Subscribe To Our Newsletter & Stay Updated
